These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


507 related items for PubMed ID: 3477662

  • 21. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC, Harris JW.
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
    [Abstract] [Full Text] [Related]

  • 22. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
    Guichard M, Lespinasse F, Malaise EP.
    Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
    [Abstract] [Full Text] [Related]

  • 23. Glutathione as a determinant of cellular response to doxorubicin.
    Lee FY, Vessey AR, Siemann DW.
    NCI Monogr; 1988 Jan; (6):211-5. PubMed ID: 3352767
    [Abstract] [Full Text] [Related]

  • 24. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line].
    Bier H.
    Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456
    [Abstract] [Full Text] [Related]

  • 25. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL, Wedner HJ.
    J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
    [Abstract] [Full Text] [Related]

  • 26. Influence of glutathione on the induction of chromosome aberrations, delay in cell cycle kinetics and cell cycle regulator proteins in irradiated mouse bone marrow cells.
    Ray S, Chatterjee A.
    Int J Radiat Biol; 2007 May; 83(5):347-54. PubMed ID: 17457759
    [Abstract] [Full Text] [Related]

  • 27. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells.
    Dusre L, Mimnaugh EG, Myers CE, Sinha BK.
    Cancer Res; 1989 Feb 01; 49(3):511-5. PubMed ID: 2535960
    [Abstract] [Full Text] [Related]

  • 28. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 29. Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity in mammalian cells and human tumor cells in vitro.
    Jin YZ, Ding L, Shen ZF, Cai RM, Xu LM, Yang JK, Jin XQ, Lu WQ, Xu JF.
    Chin Med J (Engl); 1992 Aug 15; 105(8):647-50. PubMed ID: 1458967
    [Abstract] [Full Text] [Related]

  • 30. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
    O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF.
    J Clin Oncol; 1996 Jan 15; 14(1):249-56. PubMed ID: 8558205
    [Abstract] [Full Text] [Related]

  • 31. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA, Lehman CM, Biaglow JE, Peck VM.
    Radiat Res; 1988 May 15; 114(2):215-24. PubMed ID: 3375425
    [Abstract] [Full Text] [Related]

  • 32. SR-2508 plus buthionine sulfoximine or SR-2508 alone: effects on the radiation response and the glutathione content of a human tumor xenograft.
    Lespinasse F, Biscay P, Malaise EP, Guichard M.
    Radiat Res; 1987 Apr 15; 110(1):149-54. PubMed ID: 2951766
    [Abstract] [Full Text] [Related]

  • 33. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP, Favier D, Parsons PG.
    Cancer Res; 1989 May 01; 49(9):2327-31. PubMed ID: 2706620
    [Abstract] [Full Text] [Related]

  • 34. Chemosensitization by buthionine sulfoximine in vivo.
    Tsutsui K, Komuro C, Ono K, Nishidai T, Shibamoto Y, Takahashi M, Abe M.
    Int J Radiat Oncol Biol Phys; 1986 Jul 01; 12(7):1183-6. PubMed ID: 2427490
    [Abstract] [Full Text] [Related]

  • 35. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ.
    Cell Mol Biol Res; 1995 Jul 01; 41(2):131-6. PubMed ID: 8581064
    [Abstract] [Full Text] [Related]

  • 36. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ.
    Cancer Res; 1993 Aug 15; 53(16):3662-6. PubMed ID: 8101766
    [Abstract] [Full Text] [Related]

  • 37. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
    Wong M, Helston LM, Wells PG.
    Teratology; 1989 Aug 15; 40(2):127-41. PubMed ID: 2772848
    [Abstract] [Full Text] [Related]

  • 38. Glutathione depletion, radiosensitization, and misonidazole potentiation in hypoxic Chinese hamster ovary cells by buthionine sulfoximine.
    Clark EP, Epp ER, Biaglow JE, Morse-Gaudio M, Zachgo E.
    Radiat Res; 1984 May 15; 98(2):370-80. PubMed ID: 6539482
    [Abstract] [Full Text] [Related]

  • 39. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC.
    Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of the protective effect of cyclophosphamide by pre-treatment with buthionine sulfoximine.
    Carmichael J, Friedman N, Tochner Z, Adams DJ, Wolf CR, Mitchell JB, Russo A.
    Int J Radiat Oncol Biol Phys; 1986 Jul 01; 12(7):1191-3. PubMed ID: 3744939
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 26.